OpinionPublished 23 Nov 2021

The differential diagnosis:Hemolytic uremic syndrome

Authors: Tim David

Journal of Renal Medicine

Volume 5 · Issue 2 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Hemolytic uremic syndrome (HUS) is a clinical disease that includes thrombotic microangiopathy, thrombocytopenia, and acute kidney damage as a triad. Hemolytic uremic syndrome is a set of illnesses with a variety of etiologies, resulting in variations in presentation, therapy, and prognosis. In recent years, improved knowledge of HUS, particularly those caused by genetic abnormalities in the alternative complement pathway, has resulted in revisions to the disease's nomenclature, categorization, and therapy. In addition to STEC-HUS, which is the most frequent cause of HUS in children, this review will present an updated categorization of the condition as well as current diagnostic and therapeutic options for complementmediated HUS. The triad of microangiopathy hemolytic anaemia, thrombocytopenia, and acute renal injury characterises hemolytic uremic syndrome (HUS). One of the most prevalent causes of acute renal failure in children is this condition. The clinical manifestations of hemolytic uremic syndrome are caused by thrombotic microangiopathy (TMA).

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.

Try:

More from this journal

The newest in Journal of Renal Medicine.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Renal Medicine
  • SubjectNephrology & Urology
  • BylineArticles whose byline prints “Tim David”